Régis Mulot - Global
Skip to main content
Ipsen Home Page
Press shift tab to select search category

Loading...
  • Newsroom arrow down
      < Back
    • Newsroom
    • Press Releases
    • Media Statements
    • Media Library
    • Contacts
    • Subscribe
  • Investors arrow down
      < Back
    • Investors
    • Investors
    • Financial Results
    • Annual Reports & Accounts
    • Investor Events
    • Financial Calendar
    • Corporate News
    • Regulated Information
    • Shareholder Information
    • Contacts
    • Subscribe
  • Careers arrow down
      < Back
    • Careers
    • Careers
    • Working at Ipsen
    • Culture
    • Job Search
  • Contacts arrow down
      < Back
    • Contacts
    • Contacts
    • Our Locations
    • Report Side Effects
    • Subscribe
  • Press shift tab to select search category

    Loading...
  • English  EN     Français  FR     EN  arrow_down
    • English EN
    • Français FR
  • Global Global
    < Back
    • Global EN FR
    • Annual Report EN FR
    • Americas
    • Asia Pacific
    • Europe
    • Middle East & Africa
    • United States
    • Brazil
    • Canada
    • Mexico
    • Australia
    • China
    • Singapore
    • South Korea
    • Japan
    • Belgium
    • Ukraine
    • UK
    • Germany
    • France
    • Nordics
    • Greece
    • Italy
    • Netherlands
    • Spain
    • Poland
    • Russia
    • Slovakia
    • Czech Republic
    • Austria
    • Switzerland
    • UAE & Gulf
  • Home
  • Company
      < Back
    • Company
    • Company
    • Leadership
    • History
    • Fondation Ipsen
  • Expertise
      < Back
    • Expertise
    • Oncology
    • Rare Disease
    • Neuroscience
    • Medicines
  • Science
      < Back
    • Science
    • Science
    • Profiles
    • Pipeline
    • Partnering
    • Clinical Trials
        < Back
      • Clinical Trials
      • Lay Summaries
      • Find Clinical Trials
  • Sustainability
      < Back
    • Sustainability
    • Sustainability
    • Environment
    • Patients
    • People
    • Governance
    • Our Standards
  • Patients
      < Back
    • Patients
    • Patients
    • Together for Oncology
    • Together for Rare Disease
    • Together for Neuroscience
    • Collaborate with us
  • Stories
  1. Home
  2. Company
  3. Leadership Team
  4. leadership

Régis Mulot

Post navigation

Previous
Next
Régis Mulot

Régis Mulot

  • Executive Vice President,
  • Chief Human Resources Officer
  • Follow in LinkedIn

Régis Mulot joined Ipsen in March 2018 as Executive Vice President, Chief Human Resources Officer.

Prior to joining Ipsen, Régis served as Executive Vice President, Chief Human Resources Officer at Staples Inc., the global specialty retail and e-commerce company and led a global team of over 600 professionals. Prior to his career with Staples (2009-18), Régis held HR leadership positions with Levi Strauss & Co (2002-08) and the technology start-up Broadnet Europe (2000-02), following earlier roles at GTECH Corporation (1994-2000), International Post Corporation (1991-94) and Chronopost SA (1989-91).

Régis served on the Board of Trustees, Simmons College (Boston, MA, USA); is Past Chairman of the Business Advisory Committee of the Simmons School of Management 2014-2017; Founder and former chair of the French-American HR Forum since 2016-2018. He has been co-chair of the Boston CHRO (Chief Human Resources Officers) Leadership summit between 2014 and 2018 and is a Gartner CHRO Leadership Board member since 2017.

Régis holds a DESS Entreprises Publiques (Master in Public Administration) from Paris XI-Sud in partnership with Paris IX-Dauphine and Institut International d’Administration Publique (IIAP). He also holds a Maîtrise Droit Public (Bachelor of Law) from Paris II–Panthéon-Assas and is a Beta Gamma Sigma honoree from the Simmons College Chapter.

IPN price

€103.40

 €2.30 (2.28%)

  • Media Library
  • Annual Report
  • Contacts
  • Our Locations

Ipsen logo
LinkedIn Instagram Facebook Youtube
  • Terms & Conditions
  • Cookie Policy
  • Privacy Policy

© Ipsen Pharma. All rights reserved - 2025

You are now leaving the Ipsen group website.To continue, please click on Continue?

Continue